Novir provides a comprehensive approach to helping you get back to your work or school confidently and quickly in these uncertain times. We seek to provide science-based large-scale testing strategies including clinical workflow suggestions, complementary testing types and employer and campus programs which allow for efficient patient and community management and a more wholistic approach to infection management. Our quality controlled rapid serological antibody tests (RSAT™) gives answers to whether a person has developed antibodies to SARS-CoV-2 (COVID-19) infection with results in 10-15 minutes at a cost significantly lower than that of other testing options. In addition, we have diagnostic testing to cover your higher risk population and deliver testing on your campus or in your facilities through partnerships to deliver an end-to-end solution that best suits your unique needs.
We provide rapid detection solutions for life-threatening infections. From earlier detection to providing input on treatment guidance and population monitoring, we want to help communities lessen the negative impact on health and society local outbreaks and global pandemics.
While the products we use all exceed the FDA guidelines, quality is a core aspect of everything we do from the initial approach to selecting suppliers that adhere to the highest manufacturing standards to partnering with certified CLIA laboratories that have passed rigorous CAP accreditation laboratory guidelines.
The Role of
A diagnostic test can show if you have an active coronavirus infection and should take steps to quarantine or isolate yourself from others. Currently there are two types of diagnostic tests which detect the virus – molecular tests, such as RT-PCR tests, that detect the virus’s genetic material, and antigen tests that detect specific proteins on the surface of the virus.
The Role of
An antibody test looks for antibodies that are made by your immune system in response to a threat, such as a specific virus. Antibodies can help fight infections. Antibodies can take several days or weeks to develop after you have an infection and may stay in your blood for several weeks or more after recovery. Because of this, antibody tests should not be used to diagnose an active coronavirus infection. Antibodies do not mean that you are immune to the coronavirus in the future, but they are an important part of tracking the overall spread of the virus and whether you have had it in the past.
The chart highlights where the progression of the COVID-19 virus and when PCR tests may be most helpful, versus when the antibodies are produced, and IgM and IgG testing would be most helpful.
Book a demo
Want to know more about how Novir can help your company get its employees back quickly and safely?
Book a demo below and we will get back to you as soon as possible.
Novir is providing testing based on tests from various manufacturers. Such tests have either received an emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) or were released for use under FDA guidance, “Policy for Diagnostic Tests for Coronavirus Disease-2019 during the Public Health Emergency – Immediately in Effect Guidance for Clinical Laboratories, Commercial Manufacturers and Food and Drug Administration Staff” that was updated on May 4, 2020. Tests being performed under an EUA have not been FDA cleared or approved and Novir has completed independent validation of these tests.